Skip to content
Licensed Unlicensed Requires Authentication Published by De Gruyter May 17, 2013

Wegener granulomatosis as an uncommon cause of panhypopituitarism in childhood

  • Ozlem Kara EMAIL logo , Fatma Demirel , Banu Celikel Acar and Nilgün Cakar

Abstract

Wegener granulomatosis (WG) is a cytoplasmic antineutrophil cytoplasmic antibody (c-ANCA)-associated, multi-system, necrotizing granulomatous vasculitis. Inflammation of the nasal or oral mucosa, and lung and kidney involvements are typical in the course of the disease. In rare cases, pituitary involvement may occur and cause panhypopituitarism. Pituitary involvement is very rare, and only two pediatric case reports have been published to date out of a total of 24 cases. This is a case report of an adolescent patient who presented with panhypopituitarism symptoms and was later diagnosed with WG. A 16-year-old female patient complained of fever, headache, purulent nasal discharge and severe muscle and joint pain. Additionally, she had polyuria and polydipsia. Investigations revealed a pituitary mass and panhypopituitarism. Positivity of c-ANCA and renal biopsy result compatible with WG confirmed the diagnosis.


Corresponding author: Ozlem Kara, MD, Department of Pediatric Endocrinology, Ankara Child Disease Hematology and Oncology Training Hospital, Ankara, Turkey, Phone: +90 5332579145, Fax: +90 3123472330, E-mail:

References

1. Wegener F. About a peculiar rhinogenic granulomatosis with marked involvement of the arterial system and kidneys. Beitr Pathol Anat 1939;29:30–68.Search in Google Scholar

2. Woywodt A, Haubitiz M, Haller H, Matteson EL. Wegener’s granulomatosis. Lancet 2006;367:1362–6.10.1016/S0140-6736(06)68583-8Search in Google Scholar

3. Ozen S, Ruperto N, Dillion MJ, Bogga A, Barron K, et al. EULAR/PreS endorsed consensus criteria for the classification of childhood vasculitides. Ann Rheum Dis 2006;65:936–41.10.1136/ard.2005.046300Search in Google Scholar

4. Yong TY, Li JY, Amato L, Mahadevan K, Phillips PJ, et al. Pituitary involvement in Wegener’s granulomatosis. Pituitary 2008;11: 77–84.10.1007/s11102-007-0021-2Search in Google Scholar

5. Santoro SG, Guida AH, Furioso AE, Glikman P, Rogozinski AS. Panhypopituitarism due to Wegener’s granulomatosis. Arq Bras Endocrinol Metab 2011;55:481–5.10.1590/S0004-27302011000700008Search in Google Scholar

6. Mclntyre EA, Perros P. Fatal inflammatory hypophysitis. Pituitary 2007;10:107–11.10.1007/s11102-007-0016-zSearch in Google Scholar

7. Hoffman GS, Kerr GS, Leavitt RY, Hallahan CW, Lebovics RS, et al. Wegener granulomatosis: an analysis of 158 patients. Ann Intern Med 1992;116:488–98.10.7326/0003-4819-116-6-488Search in Google Scholar

8. Bosch X, Guilabert A, Font J. Antineutrophil cytoplasmic antibodies. Lancet 2006;368:404–18.10.1016/S0140-6736(06)69114-9Search in Google Scholar

9. Pivonello R, De Bellis A, Faggiano A, Di Salle F, Petretta M, et al. Central diabetes insipidus and autoimmunity: relationship between the occurrence of antibodies to arginine vasopressin-secreting cells and clinical, immunological and radiologic features in a large cohort of patients with central diabetes insipidus of known and unknown etiology. J Clin Endocrinol Metab 2003;88: 1629–36.10.1210/jc.2002-020791Search in Google Scholar PubMed

10. Seror R, Mahr A, Ramanoelia J, Pagnoux C, Cohen P, et al. Central nervous system involvement in Wegener granulomatosis. Medicine 2006;85:54–65.10.1097/01.md.0000200166.90373.41Search in Google Scholar PubMed

Received: 2013-1-23
Accepted: 2013-4-18
Published Online: 2013-05-17
Published in Print: 2013-10-01

©2013 by Walter de Gruyter Berlin Boston

Downloaded on 25.5.2024 from https://www.degruyter.com/document/doi/10.1515/jpem-2013-0033/html
Scroll to top button